Abstract
Estimations are that 60% of women who suffer from migraines experience attacks that are associated with menstruation. Menstrual migraines are typically more debilitating, more painful, and of longer duration. Menstrual migraines are mainly managed by the same pharmacological treatments as non-menstrual migraine, however these treatments are less effective for menstrual migraine attacks. Remote electrical neuromodulation (REN) is a non-pharmacological abortive treatment for migraine headache. The current analysis is the first to explore REN's effectiveness and tolerability in menstrual migraine.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
